Filing Details
MIRA PHARMACEUTICALS, INC. (NASDAQ:MIRA) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event.
8k filedNASDAQ:MIRA
MIRA PHARMACEUTICALS, INC. (MIRA) Reports Material Event to SEC
Filing Details MIRA PHARMACEUTICALS, INC. (NASDAQ:MIRA) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event. Market Context…
Market Context
MIRA PHARMACEUTICALS, INC.'s stock currently trades at $0.91 with a market capitalization of $61.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for MIRA PHARMACEUTICALS, INC.'s stock.
All SEC filings for MIRA PHARMACEUTICALS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MIRA Stock Page
Frequently Asked Questions
Where can I read MIRA's SEC filings?
Browse all filings on our MIRA SEC filings page.
What types of SEC filings does MIRA PHARMACEUTICALS, INC. file?
Public companies like MIRA PHARMACEUTICALS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.